Idogen AB

Logo Hoodin
Hoodin AB
Mar 11, 2017
Logo Initiator Pharma
Initiator Pharma
Apr 18, 2017

Idogen AB

Logo Idogen

Idogen AB

Idogen develops a unique treatment concept to induce immunological tolerance. The method is based on autologous cell therapy with the patient’s own dendritic cells and pharmacological upregulation of the endogenous enzyme IDO-1 with the drug Zebularine in these cells.

The company was founded in 2008 on the principle discovered by Professor Leif G. Salford, Professor Hans-Olov Sjögren, Professor Bengt Widegren and Professor Bertil Persson at Lund University.

Idogen AB
Medicon Village
Scheelevägen 2
SE 223 63 Lund
info@idogen.com